Back to screener
Aspira Pathlab & Diagnostics Limited
₹115.00
▲ 5.47 (+4.99%) today
Latest quote · Yahoo Finance
Market Cap
₹118 Cr
P/E (TTM)
—
P/B
9.7
Book Value
₹11.89
ROE
-3.3%
Div Yield
—
D/E
0.27
EPS (TTM)
₹-0.45
52W High
₹135.88
52W Low
₹49.00
Sales Growth
+17.60%
Profit Growth
—
Day High
₹115.00
Day Low
₹115.00
Volume
87
Fundamentals refreshed 20 hr ago · Statements just now · Source: Yahoo Finance
Quick Take
- • Trading at n/a trailing earnings
- • Moderate ROE at -3.3%
- • Low leverage (D/E 0.27)
- • No dividend data
- • Operating margin -1.1% · Net margin -1.6%
- • Profit growth — YoY · Beta 0.42
Employees: 168
Latest quarter · Jun 2026
| ₹ Cr | Jun 2026 | QoQ | YoY |
|---|---|---|---|
| Revenue | 6 | -14.29% | +20.00% |
| Operating Profit | 0 | — | -100.00% |
| Net Profit | -0 | +100.00% | — |
| EPS (₹) | -0.04 | +94.03% | -108.70% |
OPM 7.5% · Net margin -0.6% · prev quarter OPM -3.0%
Shareholding Pattern
Numbers in percentages · Source: Yahoo Finance
Promoters / Insiders91.90%
Public & Others8.10%
About the company
From latest AR & concall Reading the latest annual report and earnings call… (1–3 min on first visit)
Aspira Pathlab & Diagnostics Limited owns, manages, runs, and administers various diagnostics centers primarily in India. The company offers biochemistry, hematology, histopathology, microbiology, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigation services. It also provides pathology, sonography, x-ray, and radiology tests. The company was formerly known as Utkal Soap Products Limited and changed its name to Aspira Pathlab & Diagnostics Limited in November 2016. Aspira Pathlab & Diagnostics Limited was incorporated in 1973 and is based in Mumbai, India.
